OBSIDIAN - real-world evidence of originator to biosimilar drug switch in juvenile idiopathic arthritis.
Maccora I, Lombardi N, Crescioli G, Bettiol A, Bonaiuti R, Pagnini I, Maniscalco V, Marrani E, Mastrolia MV, Ravaldi C, Consolini R, Cattalini M, Vannacci A, Simonini G.
Maccora I, et al. Among authors: bonaiuti r.
Rheumatology (Oxford). 2022 Apr 11;61(4):1518-1528. doi: 10.1093/rheumatology/keab572.
Rheumatology (Oxford). 2022.
PMID: 34273158